PartnershipAug 6, 2026, 08:55 AM
Silo Pharma's QwikAgents Partners with Caylent for AWS-Native Platform
AI Summary
Silo Pharma announced that its wholly owned subsidiary, QwikAgents, has partnered with Caylent, an Amazon Web Services (AWS) Premier Tier Services Partner, to develop a new AWS-native QwikAgents platform. This collaboration is designed to enhance the platform's scalability, performance, and security, accelerating its commercialization and future product innovation. The engagement is also structured to receive funding support from AWS and Caylent, positioning QwikAgents for significant enterprise growth.
Key Highlights
- Silo Pharma's QwikAgents engaged Caylent, an AWS Premier Partner.
- Caylent will design and build a new AWS-native QwikAgents platform.
- The platform aims to enhance scalability, performance, and security.
- It will accelerate commercialization and future product innovation.
- The engagement is structured for AWS and Caylent funding support.
- This collaboration positions QwikAgents for enterprise growth.
Price Impact
More from SILO